Trilo Therapeutics is a biotechnology company. It also develops protein-protein interaction inhibitors to treat cancer, autoimmune diseases, infectious diseases, and others. They provide peptidomimetic binders, which combine tiny chemicals with antibodies to suppress disease-causing proteins.
This company has no teams yet